The synthetic biology market lacks technologies for the high-throughput synthesis of long DNA. This is about to change with Ribbon Biolab’s innovative processes for synthesizing DNA of subgenomic sizes. Positioning the company as a driver of the next wave of disruptive biotechnologies.

Programs proud alumni of